ArticleAntimicrobial agents and chemotherapy2018

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants.

Elizabeth G Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.